Abstract-Recent progress in bioresorbable radio frequency electronics and engineered bacteria has promised the prospect of realizing a transient microbot (TM) system for therapeutic applications. The inorganic or organic miniature robots will dissolve into the human body after completing the required tasks and cause no side-effect. In this paper, we propose a potential architecture of a TM system for transporting pharmaceutical compounds inside the body, and analyze the system using a micro-to-macro cross-scale communication model. The remote controllability and tangibility of a TM essentially lead to a touch-communication (TouchCom) paradigm. Externally maneuverable and trackable TMs are responsible for the delivery of drug particles (information molecules in the TouchCom context). The loading/injection and unloading of the drug correspond to the transmitting and receiving processes in the TouchCom framework. Subsequently, we investigate simulation tools for the propagation and transient characteristics of TMs in the blood vessels. We also define the propagation delay, path loss, as well as angular and delay spectra of targeting intensity, which are parallel to their counterpart concepts in the conventional wireless channel. Finally, our approach is illustrated with comprehensive simulation studies of targeted drug delivery by using the proposed analytical framework integrating robotics and communications at crossover length scales. The proposed methodology may find important applications in the design and analysis of TM-assisted administration of pharmaceutical compounds. 
I. INTRODUCTION

A. Background and Motivation
I
tions. The talk laid the conceptual foundations for the micro/ nanorobotics. The recent development of active semiconductors exhibiting transient behavior [2] , [3] can revolutionize research in microbotics. These systems offer remarkable levels of functionalities and can physically disappear at prescribed times and at controlled rates [3] . Furthermore, latest advances in biorobotics have promised the prospect of realizing flagellated magnetotactic bacteria. These bacteria are biodegradable and their lifespan is dependent on the micro-environmental conditions such as the temperature of blood and the width of vasculature, which is beneficial from the perspective of biocompatibility and safe in vivo operations. By combining the concepts of miniature robots and degradable electronics/engineered bacteria, we can envisage transient microbots (TMs), which are remotely controllable and biologically resorbable [4] .
Targeted drug delivery aims at delivering a therapeutic agent or drug where medication is needed without affecting other healthy parts of the human body [5] . This process can be viewed as a molecular communication system that uses principles beyond classical electromagnetism [6] - [17] . An engineered miniature transmitter releases small particles (information molecules through which messages are encoded) into a fluid propagation medium. The particles propagate by applying either passive (e.g., diffusion) or active (e.g., with molecular motors) transport schemes, and are eventually received at a miniature receiver, where messages are decoded. Under this framework, [18] applies a molecular communication model for a particulate drug delivery system. In [18] , the transmitter is the drug injection, the receiver is the drug delivery, and the channel is realized by the transport of drug particles. This analogy enables the analysis and design of the particulate drug delivery system using communication tools.
By integrating robotics and communications "at the bottom," the current work presents a TM-assisted micro-to-macro cross-scale communication model as an abstraction of targeted drug delivery in the human body. Macroscopically maneuverable and trackable TMs are employed as the vehicles carrying drug particles (i.e., information molecules). These TMs exist for medically useful time frames before gradually dissolving into biofluids via resorption by the body, and their pathway represents the channel for information exchange. The loading/injection and unloading of the therapeutic agent correspond to the transmitting and receiving processes in the context of information exchange. In this way, a novel paradigm of touch communication (TouchCom) is achieved, which provides a visual display of information flow such that the external macro-unit (MAU) can control the movement of TMs by "touching" the tangible TM-manoeuvring space with a guiding force. This communication strategy differs from the one proposed in [18] , where the drug particles diffuse passively in the blood stream without remote control and tracking.
The TM-assisted TouchCom has the potential to simplify the requirements of previous molecular communication models by taking into account that: i) micro/nanomachines cannot process complex information, perform heavy computation, or store large amounts of data; ii) micro/nanomachines cannot modify freely molecules or control accurately the molecule release/reception process for message encoding/decoding; and iii) there is no effective mechanism to account for uncertainties during the propagation process, which can be caused by various mechanisms such as random Brownian motions, irregular change of temperature or pH value, unexpected chemical reactions in the fluid environment, random decomposition or degeneration of molecules, etc. By moving most operations to the MAU, the TouchCom process only demands the simplest functionalities (sensing and manoeuvring) at TMs. Moreover, remote controllability and trackability of TMs reduce propagation delay and environmental uncertainty.
B. Main Contributions
The main contributions of the current work can be summarized as follows.
1) We propose a cross-scale system architecture to facilitate communications. Specifically, we present the constituent elements of a TM and discuss the fundamental methodology used for information transfer by establishing the useful analogy between the TouchCom and drug delivery. Subsequently, we propose a novel channel description framework for the TouchCom by defining the quantities of propagation delay, path loss, as well as angular and delay spectra of signal strength (i.e., amount of drug delivered to the targeted site), which are parallel to their counterpart concepts in the traditional wireless channel. 2) We propose simulation tools for the propagation and transient characteristics of a TM swarm in the blood vessels. The former is modeled using a fractal-based random walk process and the latter is divided into three different components due to three different phenomena: diffusion, branching, and degeneration. 3) We present the paradigm of TouchCom by applying the principle of "seeing-is-communicating" to visualize the entire process of information transfer in real time. Consequently, we can adjust adaptively the next movement of the TM swarm "on the fly" based upon the previous observation on the past trajectory of the swarm. Eventually, we propose a cognitive control engine to optimize the performance of the TouchCom.
C. Organization of the Paper
The paper is organized as follows. In Section II, we present the architecture of the proposed TM-oriented small-scale communications by establishing the analogy between the TouchCom and targeted drug delivery. We then introduce various parameters to describe the TouchCom channel with this analogy in mind.
In Section III, we analyze the simulation tools to describe the movement and transient characteristics of the TM swarm, as well as the loading/unloading operations.
In Section IV, we look into cognitive design strategies for the proposed system. Finally, Section V provides comprehensive simulation studies of targeted drug delivery to demonstrate the principles of the analytical framework, with conclusions provided in Section VI.
II. TM-ORIENTED TOUCHCOM
A. TM Model Motivated by Experimental Findings
Water soluble and biocompatible constituent materials such as silicon nanomembranes, silicon dioxide, magnesium oxide, and silk [2] have been used to manufacture radio frequency components such as antennas, rectifying diodes, transistors, capacitors, inductors, resistors, ring oscillators, etc. Subsequently, transient devices offering remarkable levels of functionalities such as sensors, actuators, power supplies, and energy harvesting subsystems have been achieved [3] . In addition, locomotiveness demanded in a TM can be accomplished with the manipulation of Lorentz forces on current-carrying wires based on magnetohydrodynamics, or on asymmetries in fluid drag forces experienced by an oscillating structure [19] . The current technology can achieve mm-sized devices. Further miniaturization of various building blocks can be realized with advancements in the fabrication processes and the constituent materials. In addition to silicon-based systems, bacteria-based systems such as the biodegradable flagellated magnetotactic bacteria developed by Martel et al. [20] - [25] are also considered as possible TMs for our TouchCom paradigm. The use of bacteria as TMs has been discussed in our previous works [26] , [27] .
Nanocomposites can be loaded onto TMs by utilizing biological or chemical bonding methods [8] . The nanocomposites can also be functionalized by means of proper molecular groups such as peptides or antibodies, which are able to bind to receptors at the unloading destination [8] . In order to deliver sufficient amount of nanocomposites to a destination, a swarm of TMs can be injected simultaneously [20] , [21] . Based on these experimental findings, we have developed a conceptual model of a TM [26] , [27] , which comprises the functional elements depicted in Fig. 1 (a) and listed in Table I . It is worth noting that the navigator is implemented at the TM, but the tracking operation is performed at the MAU, as detailed in the next section. Either active or passive methods can be employed for navigation. In the former case, information molecules could be labeled with fluorescent carbon nanotubes or quantum dots. This procedure enables the nanocomposites to feed the location of the swarm of TMs directly back to the MAU [28] , [29] . In the latter case, information molecules in the form of a microwave contrast agent such as carbon nanotubes or ferroelectric nanoparticles can be employed. The nanocomposites do not provide the position of the swarm explicitly. Instead, the MAU performs differential microwave imaging to localize the swarm [26] , [30] . The one-to-one correspondence between the TM and the transient electronics or magnetotactic bacteria is illustrated in Table I .
B. System Architecture of TouchCom
We illustrate the TM-based TouchCom model for drug delivery in Fig. 1(b) , where the information molecules are theranostic agents. Nevertheless, the general framework is applicable to other use scenarios such as monitoring and control of food and water qualities, NBC (nuclear, biological, and chemical) conditions, environmental pollution, etc. The loading/injection process is the binding of drug particles to a swarm of TMs and the introduction of the swarm in the vascular network at a predefined injection site. We abstract the loading/injection operation as the TouchCom transmitting process with being the transmitted signal, where is the number of injected particles attached to the swarm and is the Dirac delta function. As illustrated in Fig. 1(b) , the MAU can apply angiography to visualize partially the inside, or lumen, of blood vessels in the human organ under examination and treatment. Current medical technologies can achieve 0.3 mm resolution with the volume CT and less than 100 with the micro-CT [31] . The MAU generates a magnetic field, and the TMs sense this field and move towards its gradient. While continuous tracking of TMs could be achieved for active navigation mode, our approach is based on defining intermediate aggregation zones (AZs), where the TMs are gathered to reduce diffusion and branching losses.
Under passive navigation mode, the position of the TM swarm is estimated upon arrival in an AZ, resulting in "footprints" observed at the MAU. These are shown as circular red regions in Fig. 1(b) . During traveling to the AZs, the TMs swim at different velocities and as such they disperse, making the density too low for tracking [20] , [21] . Consider, for example, the bacterial TMs studied in [20] , [21] , [26] . A relatively weak magnetic field is generated towards an AZ, whose size can typically be in the millimeter range. Assume that the boundary of the AZ corresponds to approximately 0.5 Gauss of magnetic field, with the center at 0 Gauss. When outside the AZ, the TMs follow the line of magnetic field. When inside the zone, the TMs are no longer influenced by magnetotaxis and begin random motions. If the TMs exit the AZ, the magnetic field forces them to move back to the zone by magnetotaxis. We abstract the propagation process [TM footprints as shown in Fig. 1(b) ] as the TouchCom channel, where the transmitted signal is sent via the active transport scheme. When the TMs reach the destination, the drug particles (information molecules) will be removed from the vehicles and get assimilated into the targeted site allowing them to perform healing actions. As the theranostic agent assists in the tracking operation, its binding to the targeted site deactivates the navigator component. Subsequently, the location where the drug particles finally accumulate will give rise to a "sink" on the visual display of the TM propagation route. As the TMs are made of biodegradable electronics or bacteria, they will dissolve in the blood after completing their tasks. We abstract the unloading operation as the TouchCom receiving process with being the received signal, where is the number of particles successfully discharged at the targeted site and is the propagation delay.
In summary, the main operations of TMs only involve propulsion and steering, which are achievable with the current micro/ nanobotic technologies. On the other hand, the complex operations of TM controlling and positioning are performed at the macroscopic MAU. Furthermore, the small-scale communication process is facilitated through a micro-to-macro system architecture. The operation procedure of the whole system is illustrated in Fig. 2 . Note that the loop incorporating both controlling and tracking steps underlies the TouchCom principle to be elaborated in Section IV. 
C. Description Methods for the TouchCom Channel
Structures of human vascular systems have been widely described using complex geometrical (fractal) models according to principles of optimal network formation [32] , [33] . The whole vascular tree is approximated by a dichotomously branching system of tubes known as bifurcation as illustrated in Fig. 3 . More details on the model of vasculature will be discussed in Section III-A. The signal observed at the receiver has a random amplitude, delay, and angle due to the irregular vasculature. The directional impulse response widely used in describing traditional wireless channels can be applied to the TouchCom channel. Nevertheless, while traditional channels often exhibit multipath phenomena, the TouchCom channel comprises only a single path, which can be expressed as (1) According to this model, the impulse response depends on three random variables, the path loss , the delay and the azimuth . As illustrated in Fig. 3 , we define a receiving circular zone, representing the tumor microenvironment (microvasculature). The path loss is caused by three different signal attenuation mechanisms, namely, diffusion, branching, and degeneration, which can occur during propagation of TMs from the injection site to the boundary of the receiving zone. The delay depends on the propagation route and the speed of TMs. Finally, the azimuth is defined as the angle-of-arrival at the receiving zone as depicted in Fig. 3 .
As in the analysis of wireless channels, we can develop a spatial-temporal description of TouchCom channels. The most fundamental quantity is the delay-azimuth spectrum, computed by averaging over all impulse responses:
where denotes the expectation operator. The normalization factor ensures that Ξ is a probability density function (pdf).
Following (2), the TouchCom channel azimuth spectrum and delay spectrum are derived as
The formulations apply to the ensemble average of many spatial realizations of the vascular network, such that the descriptions can be expressed as a continuous spectrum. The parameters in (3) and (4) are parallel to the definitions of power azimuth spectrum and power delay spectrum in classical wireless channels [34] , [35] . We can also apply different ways to characterize the amount of TouchCom signal dispersion in the spatial domain, which measures the width of azimuth spectrum. One approach follows the classical definition in [35] :
where
Alternatively, if the azimuth spectrum has a symmetric shape with respect to the line-of-sight direction , the angular spread can be defined as Ξ (7) where is the maximum azimuth. This parameter defines the supremum limit of angular extent, within which the percentage of received signal strength as compared to the total strength is less than a sufficiently large value .
Suppose that the delay spectrum is a non-increasing function due to the increased path loss with delay. The delay spread can be defined in a similar way to (7): Ξ (8) where and are the minimum and maximum delays. The azimuth and delay spectra will give us a clear understanding of how the drug particles arrive at the targeted site in terms of their distributions over direction-of-arrival and timeof-arrival, which is of primary importance for the design of drug delivery systems and the study of drug absorption in cancer therapy.
III. SIMULATION MODELS
We present simulation models of the movement and transient characteristics of a TM swarm in vasculature. We first look into the scenario when the blood vessels are resolvable on the angiogram. Subsequently, we will describe the models when the blood vessels are angiographically unresolvable.
A. Movement of TM Swarm in Vasculature
In order to synthesize the movement of a TM swarm in the blood vessels, a model to characterize the vascular network should be constructed. Vasculature in the human body has two basic functions [32] . Firstly, the distributive function is to bring a stream of blood to every living cell within the body or organ and is achieved by successive dichotomous division, or bifurcation. The self-similarity of bifurcation at each node gives the vascular connection a fractal character. Secondly, the hemodynamic function is to increase the cross-sectional area available to the blood flow in order to bring its velocity down to a level sufficiently low to permit the exchange of metabolic products across the capillary wall. This function governs the relationship between the diameter of the parent vessel and the diameters of two daughter vessels at each node, which follows the generalized Murray's law [32] , [33] : (9) where subscript indicates the parent segment and subscripts , 1 and , 2 indicate the two daughter segments at the same bifurcation. The exponent is called the bifurcation exponent, which ranges from 2.0 to 3.0 and determines the fractal dimension of a vascular tree. According to [33] , is equal to 2.6 2.7 for the human arterial vessels. For large arteries of systemic circulation is around 2.33. For capillaries is near 3. The vessel length is proportional to its diameter: (10) where is a constant for given vessels. For small arteries or capillaries . Vascular bifurcations often exhibit asymmetric structure such that the two branch diameters differ from one junction to the other. Define the ratio of the two diameters (11) For arterial vessels is in the range of 0.59 0.83 [33] . Substituting (11) into (9) yields (12) The self-similarity fractal dimension, , is defined as [32] 
Murray's formula also describe the angle between two daughter vessels. Define and to be the angles between daughter branch 1 and the parent segment, and daughter branch 2 and the parent. The following relationships can be obtained [33] :
The total branch angle between two daughter vessels after division is known as bifurcation angle, which ranges between 75 and 90 . The minimum angle 75 is obtained when the two daughter branches are equal. Arterial branching angle falls roughly in the range of 60 80 . For capillaries this angle is between 80 and 90 .
Real-life physiological data exhibit a large amount of scatter in the values of vessel diameters or in the values of bifurcation exponent [32] . This wide variability in branching data should be incorporated in the simulation studies. Furthermore, as some capillaries are so slender that they can hardly be imaged, the resolvable and unresolvable segments in the vascular network should be identified to represent a realistic angiogram.
Based on the fractal character of vascular branching, we propose a random walk process on the vascular tree as the baseline model for simulating the propagation of a TM swarm. The algorithm involves the following steps.
1) Let represent the initial position of the swarm, which is determined by the injection site and is assumed to be located on a root vessel with diameter and length . The initial direction is chosen to be aligned with the root vessel at . Generate a random bifurcation exponent and a random asymmetry ratio , which are uniformly distributed in the intervals and , respectively. These two intervals are dependent on the type of blood vessel. Let represent the time-varying speed of the swarm, which depends on the propelling mechanism, the blood velocity, and the blood pressure. Let . 2) At the th bifurcation, calculate the diameters of two daughter segments, and , by substituting , , and into (12) . Calculate two junction branch angles and , by substituting , and into (14) . Generate a binary random number that determines the branching direction (i.e., which of the two asymmetrical branches generated at the th bifurcation level has a larger diameter). 3) At the th bifurcation, generate a random vessel length , which has an exponential distribution of mean [see also (10) ]:
Similarly, generate another exponentially-distributed vessel length with mean . Subject to a specific controlling strategy as to be discussed in Section IV, select the th daughter segment to be the traveling path after the th bifurcation. Define and . Generate two random variables and , uniformly distributed in the intervals and , respectively. 
B. Transient Characteristics of TM Swarm
We then consider the characteristic models for the transient kinetics of a TM swarm, which can be divided into three different components caused by three different mechanisms: diffusion, branching, and degeneration. Each mechanism reduces certain percentage of the effective TMs in the swarm, and the overall transience is characterized by the multiplicative effect of these three components. Similarly, we first consider the situation that the vasculature is angiographically resolvable.
1) Diffusion: Based on experimental findings (see, e.g., [21] ), we assume that an agglomeration of TMs are controlled like a unified organism to swim in the biofluid medium. The number of TMs for each swarm will be typically large. It is thus convenient to deal with their count or concentration in various volumes of space. The diffusion occurs in a controlled environment in one dimension (i.e., blood vessel). Between the th and bifurcations, suppose that the TM swarm moves in a blood vessel whose cross-sectional area is and the inside wall of the vessel is impervious to the TMs. As a coarse approximation, we could quantify the TM diffusion with respect to the centroid of the swarm by using the result in [36] : (16) where is the number of TMs at the th AZ between the th and bifurcations, is the diffusion coefficient of the biological medium in , is the propagation time, is the distance between an arbitrary TM and the centroid of the swarm, and is a scaling factor accounting for the discrepancy between the realistic propagation scenario in a blood vessel and the ideal case in an infinite tube with a perfect reflecting barrier at the source end of the tube. Assume that there is some threshold density such that the MAU tracking the swarm responds to concentrations of and greater. The limit distance of the threshold volume is for , Otherwise
This distance increases through time to a maximum, , at time , then decreases to zero at which time the concentration is everywhere below threshold. The time of ultimate fade out is .
Subsequently, when only the diffusion loss is considered, the amount of TMs at the AZ is obtained as (18) where is the traveling time from the th to AZ, is the distance between the AZ and the th bifurcation, and is the Gauss error function. The superscript denotes diffusion. 2) Branching: At the th bifurcation (see also Fig. 3 ), when the parent and daughter blood vessels are visible on the angiogram, an AZ at the entrance of the intended daughter branch can be set up to greatly reduce the branching effect. In this case, we will ignore the branching loss in our simulation studies. On the other hand, if the vessels are undetectable inside the human body due to the limit in sensitivity of the imaging modality used, it is more difficult to maintain the convergence of TMs through a carefully set AZ. One possible remedy is to reduce the distance between two successive AZs. This, however, may not be practical in real-life applications due to constraint on drug delivery time. In the worst case, the ratio of the amount of TMs entering two daughter segments is approximated as and the branching attenuation is (assuming that the intended path is the 1st daughter vessel)
. The actual attenuation ranges between and 1 depending on the displacement between neighboring AZs, . For simplicity, we postulate the following exponential relationship between and : (19) The term is the rate parameter, which is comparable to the length of the blood vessel.
3) Degeneration: This measure quantifies the effect of bioresorption, which is normalized such that it ranges from 0 (no resorption) to 1 (complete resorption).
Following the experimental findings reported in [2] , [3] , in terms of a silicon-based TM, the system exhibits two-stage kinetics in its functional transience. For example, immersion of metal-oxide-semiconductor field-effect transistors formed using silicon nanomembranes, silicon dioxide gate dielectrics, and magnesium electrodes, with encapsulating layers of magnesium oxide and silk, in deionized water for up to 90 hours caused small change in key device properties. Significant functional degradation then occurred in a narrow time interval ( 3 hours) after this period of stable operation. The encapsulation defines the first time scale, whereas the magnesium electrodes define the second. A similar phenomenon was found in the dissolution behavior of other diode devices [2] , [3] . Furthermore, a transient bioresorbable device for thermal therapy was implanted under the skin of a Sprague-Dawley rat. Inductive coupling through the skin generated a localized temperature increase to sterilize and maintain asepsis at the wound site. The functional transience had a time scale of 15 days, which was controlled via the crystallinity of the silk package. After this time, the device quickly disappeared [3] .
Consequently, to synthesize the two-stage kinetics as well as random bioresorbing, we model the transient characteristics based on a dual-slope Lévy process: (20) where represents the initial condition at when the TM swarm has just been injected without any bioresorption. and are the transient characteristic and total duration of immersion, respectively, when the TMs arrive at the th AZ.
satisfies the following properties of a Lévy process: i) almost surely; ii) (independence of increments) for any , , are independent; iii) (stationary increments) for any , is equal in distribution to ; and iv) (continuity in probability) for any and it holds that . We consider the exponential process where the probability distribution of is an exponential distribution with expected value . In the dual-slope Lévy process, are the rates of the two-stage bioresorbing process. Note that the degeneration of TMs in the biofluid medium is irreversible and therefore, is a non-decreasing sequence. An indicator function is defined as
The indicator terms in (20) switch the value of between (for ) and 1 (for ), where the maximum value of 1 indicates complete bioresorption. Furthermore, the critical point determines the boundary of the two regimes of transient kinetics. Finally, the two parameters and are the functional lifespan and physical lifespan of TMs, respectively.
In terms of a bacterial TM, the degeneration process is related to decrease in its terminal velocity. Initial experiments conducted in human blood at 37 showed that the velocity (in ) at a time (expressed in minutes) after the beginning of operations of the magnetotactic bacteria decreased according to [20] ( 22) where is the initial average velocity of the bacteria prior to being injected into blood. The bacteria would remain effective for a duration of 40
, and the decrease in speed was probably caused by the relatively high temperature of blood. The second-order polynomial regression model in (22) is not convenient for simulation studies and theoretical analysis. Instead, we propose to use an exponentially decaying function to approximate the swimming speed of the bacteria in blood: (23) where determines the decaying rate of speed with respect to time. To approximate the relationship in (22) , is chosen to be around 15 minutes by visual inspection.
The swimming speeds from a large sample of magnetotactic bacteria have been measured by Martel et al. with a video camera mounted on an optical microscope in reflection-mode microscopy using dark-field illumination [20] . Based on the observation in [20] , we could model the terminal velocity distribution of the bacteria using a truncated Gaussian pdf with mean and standard deviation (i.e., without a priori selection) or (i.e., with a priori selection). As shown in [20] , the minimum and maximum speeds are given by and , respectively. Suppose that the threshold velocity below which a bacterium is deemed degenerated is . The percentage of effective bacteria upon arrival at the th AZ, where the total immersion time is , can be calculated as the probability that the random velocity of an arbitrary bacterium, , is less than :
(24)
C. Derivation of TouchCom Channel Parameters
When the TM swarm reaches the targeted site, the percentage of drug consumed during the propagation phase (i.e., the path loss) can be derived by accounting for the three transience mechanisms mentioned above: (25) where is the total number of bifurcations, is the number of AZs at the th bifurcation, the AZ is the tumor microvasculature as shown in Fig. 3, and is the total number of AZs.
denotes the initial number of TMs in the swarm. Furthermore, for
. The three terms in (25) correspond to the diffusion, branching, and degeneration losses, respectively. Substituting (18)- (20) and (24) into (25) yields the overall path loss. The overall delay is given by the submission of all propagation delays between consecutive AZs as well as the tracking times at these zones. Furthermore, as illustrated in Fig. 3 , the incident angle is defined as the angle between the line joining the center of the receiving circular zone (tumor microvasculature) and the point where the TM path intersects the receiving zone and the horizontal axis.
D. Simulation Models for Angiographically Unresolvable Vasculature
When the blood vessels are too tiny to be imaged, the vascular network could be approximated as a homogeneous fluid medium. Subsequently, the movement of the TM swarm can be modeled using a velocity-jump random walk process [4] . We assume that the swarm moves forward with a time-varying speed for a time step of random length, which is governed by a Poisson process with turning frequency . Hence, the mean run length time is
. The swarm then changes its direction, with the new direction (angle) generated via the von Mises pdf, which has been commonly employed in the simulation of correlated random walks for the distribution of turning angle at each step [37] . The mean of this pdf depends on the propelling field at the present location of the swarm and thus introduces a directional bias. Our simulation algorithm involves the following steps: 1) Let represent the initial position of the swarm, which is determined by the location where it enters the unresolvable zone on the angiogram. The initial direction is chosen to be aligned with the external field at . Let represent the speed of the swarm, the turning rate, and the concentration parameter of the von Mises velocity (direction) jump. Let . 2) Obtain a random time step as a result of a Poisson process of intensity . Consequently, follows an exponential distribution of mean , with pdf (26) Obtain a random angle from the von Mises distribution of mean 0 and concentration , using an envelope-rejection method based on a wrapped Cauchy distribution [38] . The pdf is given by (27) where denotes the modified Bessel function of the first kind and order 0. The distribution is unimodal and is symmetrical about 0. The mode is at and the width of the angular spread is controlled by . For , the pdf is equal to the uniform distribution; while yields a sharply peaked distribution about 0.
3) Obtain the new position from the old position , given and generated in Step 2, using the simple trigonometry as follows: (28) and (29) where is the angle of the external field at . 4) Increment by 1 and go to Step 2, unless a stopping condition is reached (e.g., the swarm dissolves into the blood or reaches the tumor microenvironment). The next step is to characterize the transient behavior of the TM swarm. Firstly, the diffusion and branching effects can be combined into a two-dimensional diffusion process with respect to the centroid of the swarm [36] : (30) where is the amount of TMs at the initial position in the unresolvable zone, is the diffusion coefficient of the biological medium in , is the propagation time, and is the distance between an arbitrary TM and the centroid of the swarm. Similar to (17) , assume that there is some threshold density such that the MAU tracking the TMs responds to concentrations of and greater. The line of concentration of at time is a circle with center at the centroid and radius if , Otherwise
Subsequently, the average number of TMs at the th AZ is obtained as (32) where is the propagation time from the moment the swarm enters the unresolvable region to the th AZ in the region. Equation (32) ignores the TM diffusion loss outside AZs and assumes that the time spent in traveling from one AZ to another is much longer than the time spent at each AZ.
In terms of the degeneration loss, the same models as those in (20)- (24) can be applied.
E. Limitation of the Proposed Models
The TM-assisted targeted drug delivery involves many complex molecular, biological, and chemical processes. In the previous sections, we have considered several major aspects in- cluding diffusion, branching, and degeneration in the proposed models. Nevertheless, the following important factors should be incorporated in future to make the models more realistic. Firstly, apart from diffusion, another mass transport phenomenon operated by the cardiovascular system for the propagation of TMs is advection as analyzed in [18] . Future work will take into account the effect of advection on the movement of TMs while in suspension in the blood and guided by magnetotaxis. Secondly, the blood velocity profile in the cardiovascular system given the flow input by the heart should be incorporated in the models. For example, [18] makes use of the Navier-Stokes equation and the transmission line theory to solve for the blood velocity. Other important parameters to be incorporated include the interactions between TMs, the interactions between TMs and the tumor, the variations in the tumor tissue microenvironment due to TMs, etc.
IV. COGNITIVE ENGINE FOR TOUCHCOM
For the proposed TouchCom framework, the external MAU is able to decide partially the propagation path of TMs. On the other hand, the movement of TMs is influenced by the unknown in vivo environment under surveillance. Furthermore, perception about the structure of blood vessels may change as further knowledge on the vascular structure is acquired by observing the movement of TMs. This, in turn, will affect the trajectory planning in the next round of TM maneuver. This feedback loop motivates adoption of the cognitive engine as shown in Fig. 4 . The engine applies previous measurements of the TM path ("environment"), and intelligently optimizes the planning of TM pathway ("control"), in response to the perceived surveillance environment variation such as the structure of the vascular network ("perception") in real time. The feedback loop from the tracking module to the propelling field source ("feedback") facilitates such a learning process. In this way, a visual display of communication channel is provided, which enables the external MAU to control the movement of TMs by "touching" the tangible TM-maneuvering space with a guiding force.
In general, there are two criteria for TM path planning. The first criterion aims at minimizing the propagation delay from the injection site to the tumor microenvironment. The second criterion attempts to minimize the attenuation loss of TM-assisted drug delivery. Depending on the structure of vasculature, these two criteria may not always lead to a unique solution. For simplicity, the following heuristic rules for the cognitive engine are proposed in line with the two criteria mentioned above.
1) When blood vessels are resolvable on the angiogram, the control process only occurs at each bifurcation. The cognitive engine chooses the daughter segment that results in the shorter perpendicular distance from the center of the tumor microenvironment to the segment as the traveling path after the bifurcation. 2) When blood vessels are unresolvable on the angiogram, a two-step control is required after the TM swarm leaves the previous AZ and is about to reach the next AZ. First, the cognitive engine identifies the area with the highest concentration of TMs as the next AZ. Subsequently, the direction of the guiding field is chosen to be aligned with the line connecting the center of the AZ and the tumor microenvironment. These two heuristic rules can be readily integrated into the simulation steps mentioned in Section III.
V. NUMERICAL EXAMPLES
We present a study case of TouchCom for silicon-based TMs assuming that an external propelling field is employed to guide the TMs for targeted drug delivery. We assume that the speed of the TM swarm is 0.03 cm/s, comparable to the average velocity of blood flow in capillaries. The time spent at each AZ is assumed to be negligible as compared to the propagation time. The injection site is located at the origin. The tumor microenvironment is a circular area centered at (10 cm, 0 cm) and having a radius of 0.5 cm. The diameter and length of the root vessel where the TM swarm is injected are 0.1 cm and 1 cm, respectively, and the vessel is aligned with the axis. The angiographically unresolvable vasculature is the region defined by , whereas the angiographically resolvable region is defined by . In the simulation studies, we will consider three different widths of the resolvable region:
. To synthesize the movement of TMs in , the bifurcation exponent and asymmetric ratio of the vascular tree are set to be uniformly distributed in [2.6,2.7] and [0.6,0.8], respectively. The length-to-diameter ratio is 40. In terms of the movement of TMs in , the following model parameters are used: and . To model the path loss, the degeneration parameters are given by , , and . We will consider three different diffusion coefficients . The two heuristic rules for the cognitive engine presented in Section IV are applied to control the movement of TMs. Fig. 5 illustrates a typical path of the TM swarm when the boundary of angiographically resolvable vasculature and the diffusion coefficient are set to be and , respectively. As can be seen from this figure, the trajectory in has longer and more regular segments as compared to . Fig. 6 shows the degeneration, diffusion, and overall losses corresponding to the trajectory in Fig. 5 . The initial path loss at the injection site is 1 because there is no signal attenuation in the beginning of the transport process. Note that the attenuation caused by diffusion increases abruptly as the TM swarm enters . On the other hand, the degeneration loss increases gradually throughout the entire transportation process.
The empirical distribution of propagation time from the injection site to the tumor, the pdf of angle-of-arrival at the tumor, and the pdf of path loss for three different values of the diffusion coefficient are shown in Fig. 7(a)-(c) based on 50000 simulation runs. Furthermore, the delay spectrum and azimuth spectrum formulated in Section II-C are depicted in Fig. 7(d)-(e) . As can be seen from Figs. 7(a) and (d), both the pdf of delay and delay spectrum first increase with delay and reach their maximum values. Then, the pdfs decrease and exhibit a long tail. The pdfs of time-of-arrival are concentrated within a broader temporal range as compared to the delay spectrum. Furthermore, various do not lead to noticeable changes in the former plots, whereas larger values of result in smaller delay spreads in the latter plots. Next, the pdf of path loss is featured by a clustering phenomenon as shown in Fig. 7(c) . It exhibits a peak at around 0 (i.e., the amount of drug delivered is completely attenuated), together with an asymmetric cluster for larger values of path loss. As decreases, the chance of successfully delivering more drug molecules increases. Finally, as illustrated in Figs. 7(b) and (e), both the pdf of azimuth and azimuth spectrum are symmetric with respect to 0 . The value of has a negligible effect on the pdf of angle-of-arrival, but has a remarkable effect on the azimuth spectrum.
We also look into the influence of different sizes of the angiographically resolvable region on the distributions. All the quantities except for the pdf of path loss are insensitive to the change in . Hence, we omit the plots here for simplicity. On the other hand, larger values of increase the chance of transporting a larger amount of drug cargoes to the tumor microenvironment as depicted in Fig. 8 .
VI. CONCLUSION
We have proposed a TM-assisted TouchCom model for targeted drug delivery, and analyzed the system architecture and simulation tools of the proposed framework. We have also presented numerical examples to demonstrate the principles of our approach. Specifically, we have investigated the distributions of the delay, angle-of-arrival, and path loss, as well as the delay spectrum and azimuth spectrum, which are important parameters from the perspectives of both drug delivery and information exchange. The TouchCom paradigm represents a unified framework that integrates robotics and communications "at the bottom," and establishes the useful analogy between the TM-based drug delivery and small-scale communications. 
